课题基金 / 基金详情

COMPARATIVE ANALYSIS OF CLINICAL AND MOLECULAR IMMUNOLOGICAL PATHOGENESES IN SUBTYPES OF MULTIPLE SCLEROSIS IN JAPAN

COMPARATIVE ANALYSIS OF CLINICAL AND MOLECULAR IMMUNOLOGICAL PATHOGENESES IN SUBTYPES OF MULTIPLE SCLEROSIS IN JAPAN
日本多发性硬化症亚型临床及分子免疫病因比较分析
批准号:
15390271
负责人:
ITOYAMA Yasuto
金额:
$6.85万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

ITOYAMA Yasuto的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Multiple sclerosis (MS) is classified into two subtypes, 1)conventional MS (CMS) in which demyelinating lesions are disseminated in the central nervous system and 2)optic-spinal MS (OSMS) characterized by the selective involvement of the optic nerves and spinal cord. We investigated clinical and molecular immunological pathogeneses of these two subtypes in Japan.1.The percentages of MS subtypes in our 120 cases were as follows, CMS (60.8%), OSMS(22.5%), spinal MS(7.5%), secondary progressive MS(5.0%), and primary progressive MS(4.1%). In contrast to CMS, none of OSMS was progressive.2.The CCR5+CD4+cell subset% and IgG1% in the cerebrospinal fluid (CSF) were significantly lower in OSMS than in CMS, suggesting less Th1 immunity in OSMS.3.Pathological features of OSMS distinct from CMS were severe tissue destruction, marked macrophage infiltration, and deposition of immunoglobulins and activated complements in the blood vessels.4.The most characteristic lesions in oligoclonal bands-positive CMS were the periventricular lesions.5.Phage display analysis of CSF IgG in CMS showed that the sequences highly homologous to herpes viruses were commonly detected as the peptides bound to the patients'IgG.6.CDR3 spectratyping analysis in MS revealed a frequent expansion of Vβ5.2+T cell clones suggesting the importance of the T cells in the pathogenesis of MS.7.Indirect immunofluorescence method with patients' sera and mouse brain tissue demonstrated a unique staining pattern specifically seen in OSMS and its high-risk group. The serum autoantibody was named NMO-IgG, and it was shown to bind to CNS microvessels, pia, subpial tissue and Virchow-Robin space. Further studies are needed to analyze NMO-IgG7s useful for early diagnosis of OSMS and its role in the pathogenesis.
期刊论文(208)
专著(0)
科研奖励(0)
会议论文
Pathogenesis, therapy and chemokines in multiple sclerosis.
多发性硬化症的发病机制、治疗和趋化因子。
DOI: --
发表时间: 2003
期刊: Neuoimmunology 11
影响因子: --
作者: [Hirano R, Takashima H, Nakagawa M, et al., Fujihara K.]
通讯作者: Fujihara K.
急性散在性脳脊髄炎
急性播散性脑脊髓炎
DOI: --
发表时间: 2004
期刊: Current Insights in Neurological Science 12
影响因子: --
作者: [Banno, M., Mizuno, T., Kato, H., Zang, G., Kawanokuchi, J., Kuno, R., Jin, S., Takeuchi, H., Suzumura, A., 藤原一男]
通讯作者: 藤原一男
多発性硬化症と髄液オリゴクローナルバンド
多发性硬化症和脑脊液寡克隆带
DOI: --
发表时间: 2004
期刊: 脳と神経 56
影响因子: --
作者: [Misu T, Hashimoto Y. et al., 藤原一男, 中島一郎]
通讯作者: 中島一郎
わが国の多発性硬化症の病型
日本多发性硬化症的类型
DOI: --
发表时间: 2004
期刊: Clinical Neuroscience 22
影响因子: --
作者: [Misu T, 小野寺淳一]
通讯作者: 小野寺淳一
84
    Establishment of a new disease entity as astrocytopathy, and studies on the pathogenesis and treatment for neuromyelitis optica
    Elucidate the pathomechanism of inclusion body myositis(IBM)
    • 批准号:
      22659167
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.12万
    • 财政年份:
      2010
    • 负责人:
      ITOYAMA Yasuto
    • 依托单位:
    Optic-spinal multiple sclerosis : clarification of pathogenesis, establishment of new disease entity and treatment
    • 批准号:
      19209032
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $26.21万
    • 财政年份:
      2007
    • 负责人:
      ITOYAMA Yasuto
    • 依托单位:
    A Study on the Pathogenesis and Therapy of Optic-Spinal Multiple Sclerosis
    • 批准号:
      17390250
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.09万
    • 财政年份:
      2005
    • 负责人:
      ITOYAMA Yasuto
    • 依托单位:
    海外基金